Frank B. Gelder, PhD
Frank B. Gelder, PhD, is founding scientist at Virionyx Corporation Ltd.
|
The Therapeutic Vaccine Potential of MIS416 Adjuvant
January 2, 2009
By:
Gill A. Webster, PhD
,
Frank B. Gelder, PhD
This article discusses the potential of MIS416 adjuvant, a vaccine adjuvant and immunogen co-delivery system, to provide adequate immunostimulation to overcome host factors that may limit the success of therapeutic vaccines.
|
|